| Type |
Details |
Score |
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
Mus pahari |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
Mus spretus |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Laes JF |
| Year: |
1998 |
| Journal: |
Cytogenet Cell Genet |
| Title: |
Assignment of the cyclin-dependent kinase inhibitor genes Cdkn2a and Cdkn2b to rat chromosome bands 5q32-->q34 and 5q31-->q33, respectively by fluorescence in situ hybridization, using small PCR-generated probes. |
| Volume: |
81 |
| Issue: |
3-4 |
| Pages: |
290-1 |
|
•
•
•
•
•
|
| Allele |
| Name: |
CDKN2A interacting protein N-terminal like; gene trap AC0187, Wellcome Trust Sanger Institute |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
CDKN2A interacting protein N-terminal like; gene trap CC0088, Wellcome Trust Sanger Institute |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
CDKN2A interacting protein N-terminal like; gene trap E175A04, German Gene Trap Consortium |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
CDKN2A interacting protein N-terminal like; targeted mutation 1a, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
CDKN2A interacting protein N-terminal like; targeted mutation 1e, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
CDKN2A interacting protein N-terminal like; targeted mutation 1b, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
CDKN2A interacting protein N-terminal like; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CDKN2A interacting protein N-terminal like; endonuclease-mediated mutation 2, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| DO Term |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2aip/Cdkn2aip<+> |
| Background: |
C57BL/6NJ-Cdkn2aip/Mmjax |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2aipnl/Cdkn2aipnl |
| Background: |
C57BL/6N-Cdkn2aipnl/Wtsi |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| DO Term |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 2, Terry Van Dyke |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tompkins V |
| Year: |
2006 |
| Journal: |
Cell Cycle |
| Title: |
Identification of novel ARF binding proteins by two-hybrid screening. |
| Volume: |
5 |
| Issue: |
6 |
| Pages: |
641-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Montalbano J |
| Year: |
2007 |
| Journal: |
J Biol Chem |
| Title: |
RBEL1 is a novel gene that encodes a nucleocytoplasmic Ras superfamily GTP-binding protein and is overexpressed in breast cancer. |
| Volume: |
282 |
| Issue: |
52 |
| Pages: |
37640-9 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Rab-like protein 6 (RABL6 or RBEL1) is one of several proteins identified as binding partners of the ARF tumour suppressor, which protects against cancer through protein-protein interactions, interacting with CDKN2A []. RABL6 binds GTP and is found either in the cytoplasm or the nucleus depending in the isoform; isoform 1 is O-glycosylated and cytoplasmic []. |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic, mutant stock |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; targeted mutation 1.1, Dmitry V Bulavin |
| Allele Type: |
Targeted |
| Attribute String: |
Recombinase, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; targeted mutation 2.1, Dmitry V Bulavin |
| Allele Type: |
Targeted |
| Attribute String: |
Inducible, Recombinase, Reporter |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(TTR-p19Cdkn2a)2Tvd/? |
| Background: |
involves: C57BL/6J * DBA/2J |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; targeted mutation 1, Charles J Scherr |
| Allele Type: |
Targeted |
| Attribute String: |
Modified isoform(s) |
|
•
•
•
•
•
|
| Allele |
| Name: |
deletion, Chr 4, Anton Berns 2 |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; targeted mutation 4, Charles J Sherr |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion GR30, GENSAT Project at Rockefeller University |
| Allele Type: |
Transgenic |
| Attribute String: |
Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; endonuclease-mediated mutation 4, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; endonuclease-mediated mutation 5, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; endonuclease-mediated mutation 1, Juan Pedro Martinez-Barbera |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Inserted expressed sequence, Recombinase, Reporter |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents to the second PHD finger found in MTF2.MTF2 (also known as PCL2), complexes with the polycomb repressive complex-2 (PRC2) in embryonic stem cells and regulates the transcriptional networks during embryonic stem cell self-renewal and differentiation []. It recruits the PRC2 complex to the inactive X chromosome and target loci in embryonic stem cells []. Moreover, MTF2 is required for PRC2-mediated Hox cluster repression []. It activates the Cdkn2a gene and promotes cellular senescence, thus suppressing the catalytic activity of PRC2 locally. MTF2 consists of an N-terminal Tudor domain followed by two PHD fingers, and a C-terminal MTF2 domain. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents the first PHD finger found in MTF2.MTF2 (also known as PCL2), complexes with the polycomb repressive complex-2 (PRC2) in embryonic stem cells and regulates the transcriptional networks during embryonic stem cell self-renewal and differentiation []. It recruits the PRC2 complex to the inactive X chromosome and target loci in embryonic stem cells []. Moreover, MTF2 is required for PRC2-mediated Hox cluster repression []. It activates the Cdkn2a gene and promotes cellular senescence, thus suppressing the catalytic activity of PRC2 locally. MTF2 consists of an N-terminal Tudor domain followed by two PHD fingers, and a C-terminal MTF2 domain. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hashimoto M |
| Year: |
2016 |
| Journal: |
JCI Insight |
| Title: |
Elimination of p19ARF-expressing cells enhances pulmonary function in mice. |
| Volume: |
1 |
| Issue: |
12 |
| Pages: |
e87732 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Walker E |
| Year: |
2010 |
| Journal: |
Cell Stem Cell |
| Title: |
Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation. |
| Volume: |
6 |
| Issue: |
2 |
| Pages: |
153-66 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Casanova M |
| Year: |
2011 |
| Journal: |
Development |
| Title: |
Polycomblike 2 facilitates the recruitment of PRC2 Polycomb group complexes to the inactive X chromosome and to target loci in embryonic stem cells. |
| Volume: |
138 |
| Issue: |
8 |
| Pages: |
1471-82 |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, targeted mutation, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, congenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, mutant stock |
|
•
•
•
•
•
|
| Allele |
| Name: |
deletion, Chr 4, Anton Berns 1 |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant stock, transgenic |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; targeted mutation 1, Makoto Nakanishi |
| Allele Type: |
Targeted |
| Attribute String: |
Inducible, Recombinase |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a |
| Background: |
involves: 129X1/SvJ * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Del(4Cdkn2a-Cdkn2b)2Brn/Del(4Cdkn2a-Cdkn2b)2Brn |
| Background: |
involves: 129P2/OlaHsd * FVB/N |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Del(4Cdkn2a-Cdkn2b)2Brn/+ |
| Background: |
involves: 129P2/OlaHsd * FVB/N |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a |
| Background: |
involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a<+> |
| Background: |
involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a<+> Kat5/Kat5<+> |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a |
| Background: |
involves: 129S1/Sv * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a |
| Background: |
involves: 129X1/SvJ |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Tacstd2/Tacstd2 |
| Background: |
involves: 129X1/SvJ * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, Masataka Sugimoto |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence, Modified isoform(s), Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 3, Jan MA van Deursen |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 5, Jan MA van Deursen |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 1, Judith Campisi |
| Allele Type: |
Transgenic |
| Attribute String: |
Reporter |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Trp53/Trp53 |
| Background: |
involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Del(4Cdkn2a-Cdkn2b)1Brn/Del(4Cdkn2a-Cdkn2b)1Brn |
| Background: |
involves: 129P2/OlaHsd |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Del(4Cdkn2a-Cdkn2b)1Brn/+ |
| Background: |
involves: 129P2/OlaHsd |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a<+> Tgfb2/Tgfb2 |
| Background: |
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a<+> Tgfb2/Tgfb2<+> |
| Background: |
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lefebure M |
| Year: |
2017 |
| Journal: |
Nat Commun |
| Title: |
Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene. |
| Volume: |
8 |
|
| Pages: |
14581 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
725
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Allele |
| Name: |
cyclin dependent kinase inhibitor 2A; targeted mutation 3, Charles J Sherr |
| Allele Type: |
Targeted |
| Attribute String: |
Recombinase |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Pdgfrb/Pdgfrb |
| Background: |
involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Trp53/Trp53 |
| Background: |
involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 * NIH/OlaHsd |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Tg(GFAP-TVA)5Hev/? |
| Background: |
involves: 129X1/SvJ * BALB/c * C57BL/6 * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Rb1/Rb1 |
| Background: |
involves: 129S2/SvPas * 129X1/SvJ |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pencik J |
| Year: |
2015 |
| Journal: |
Nat Commun |
| Title: |
STAT3 regulated ARF expression suppresses prostate cancer metastasis. |
| Volume: |
6 |
|
| Pages: |
7736 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tamayo-Orrego L |
| Year: |
2016 |
| Journal: |
Cell Rep |
| Title: |
Evasion of Cell Senescence Leads to Medulloblastoma Progression. |
| Volume: |
14 |
| Issue: |
12 |
| Pages: |
2925-37 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sethi NS |
| Year: |
2020 |
| Journal: |
Nat Genet |
| Title: |
Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model. |
| Volume: |
52 |
| Issue: |
2 |
| Pages: |
219-230 |
|
•
•
•
•
•
|